BridgeMD
Tests treatment safety and results for Coronary Artery Disease
Official title Safety and Cost-efficiëncy of New Imaging Techniques in Patients Suspected of Coronary Artery Disease
ClinicalTrials.gov ID: NCT04939207
What this study is testing
- What it's testing
- Yearly, 180 000 patients in the Netherlands are referred to a cardiologist with symptoms suspected of coronary artery disease (CAD). To assess this, multiple diagnostic tests are available.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- The subject is willing and able to provide informed consent and adhere to study rules and regulations and follow-up
- The subject is clinically suspected of having (recurrent) angina pectoris or an equivalent and suspected coronary artery disease, based on symptoms...
- The subject has had ≥64 multidetector row coronary CTA or will undergo coronary CTA as part of usual care deemed by the treating physician with ≥64...
You likely can't join if
- The subject is suffering from unstable angina pectoris.
- The subject is suffering from decompensated congestive cardiac failure.
- The subject is suffering from a known non-ischemic cardiomyopathy.
- The subject has a history of PCI or CABG.
- The subject has had pacemaker or internal defibrillator leads implanted.
- The subject has a prosthetic heart valve.
See the full eligibility criteria
- The subject is willing and able to provide informed consent and adhere to study rules and regulations and follow-up
- The subject is clinically suspected of having (recurrent) angina pectoris or an equivalent and suspected coronary artery disease, based on symptoms and signs, history, clinical examination and baseline diagnostic...
- The subject has had ≥64 multidetector row coronary CTA or will undergo coronary CTA as part of usual care deemed by the treating physician with ≥64 multidetector row coronary CTA.
- The subject is suffering from unstable angina pectoris.
- The subject is suffering from decompensated congestive cardiac failure.
- The subject is suffering from a known non-ischemic cardiomyopathy.
- The subject has a history of PCI or CABG.
- The subject has had pacemaker or internal defibrillator leads implanted.
- The subject has a prosthetic heart valve.
- There is a severe language barrier.
- The subject participates in any other clinical trial that interferes with the current study.
- Clinical condition prohibiting subsequent treatment therapy as indicated by the results of the imaging procedures.
- The subject is or might be pregnant.
- The subject does not comply or is not able to comply to the imaging guidelines for the performance and acquisition of CCTA by the Society of Cardiac Computed Tomography (SCCT), including:
- The subject is suffering from a cardiac rhythm other than sinus rhythm.
- The subject is morbidly obese (Body Mass Index (BMI) \> 40).
- The subject is not able to sustain a breath-hold for 25 seconds.
- The subject is unable to remain in supine position for at least 30 minutes.
- The subject has known allergies to or contra-indications to receiving an iodinated contrast agent. Contraindications to receiving an iodinated contrast agent: Glomerular Filtration Rate (GFR) \< 45 ml/min/1,73m2 and if...
The study team makes the final eligibility decision.
Where it's taking place
- Eindhoven, North Brabant, Netherlands
- Rotterdam, South Holland, Netherlands
- Nieuwegein, Utrecht, Netherlands
- Utrecht, Utrecht, Netherlands
Compensation & support
A stipend or compensation may be offered.
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Eindhoven, North Brabant, Netherlands; Rotterdam, South Holland, Netherlands; Nieuwegein, Utrecht, Netherlands; Utrecht, Utrecht, Netherlands. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.